Welcome to Migraine Guide
topamax migraine Links
TOPAMAX® (topiramate) for Migraine Prevention
Information about TOPAMAX® (topiramate) for migraine prevention. TOPAMAX is a migraine prevention medication that could help reduce the frequency of your ...
TOPAMAX® (topiramate) May Help Prevent Migraine Headaches According to New Data Presented at Neurology Meeting
Note: These press releases and statements were accurate, in all material respects, at the time of their issuance. ... conducted for migraine prevention demonstrate that TOPAMAX® (topiramate) Tablets and TOPAMAX® (topiramate capsules ... can help prevent migraine attacks, with effects occurring ...
TOPAMAX Migraine News
News and information on TOPAMAX, migraine, and migraine headaches.
Topamax-Epilepsy.com
... TOPAMAX Migraine. TOPAMAX can make a significant difference in the lives of people with epilepsy ... TOPAMAX is approved as initial monotherapy in patients 10 years of age and older with ...
The topamax migraine solution – is topamax the migraine drug for you?
The Topamax migraine solution - a dream come true? It's the antiepileptic drug that may bring relief to migraineurs. But is it for you?
Epilepsy Drug Fights Migraine
Topamax Prevents Chronic Migraines ... found treatment with the drug Topamax cut the number of migraine episodes in half for more than 50% of the migraine sufferers ...
Topamax is Effective for Treating Migraines
A new study has shown that Topamax - generic Topiramate - is effective for reducing the frequency of migraine headaches. Topamax is an epilepsy medication ...
topamax migraine News
J&J Profit Rises 8% as Consumer Sales Offset Slumping Drugs (Bloomberg.com)
July 15 (Bloomberg) -- Johnson & Johnson 's second-quarter earnings rose 8 percent, beating analysts' estimates, as demand for consumer products helped overcome flagging drug sales.
Read more...J&J Profit Rises on Consumer Products, Overseas Sales (Update3) (Bloomberg.com)
July 15 (Bloomberg) -- Johnson & Johnson , the world's largest maker of health-care products, said earnings rose 8 percent, beating analysts' estimates, as overseas sales increased and consumer items defied the weak U.S. economy.
Read more...Johnson & Johnson Reports 2008 Second-Quarter Results: (PR Newswire via Yahoo! Finance)
Johnson & Johnson today announced record sales of $16.5 billion for the second quarter of 2008, an increase of 8.7% as compared to the second quarter of 2007. Operational growth was 3.1% and the positive impact of currency was 5.6%.
Read more...FDA Panel Rejects Black Box Warning On Epilepsy Drugs (Medical News Today)
A panel of experts that advises the US Food and Drug Administration (FDA) voted last week to reject the Agency's proposal to make manufacturers of 11 epilepsy drugs put the strongest level of warning label on their products (the Black Box warning).
Read more...Pfizer Looking at a Level Playing Field (The Motley Fool)
An advisory panel says that epilepsy drugs don't need a black-box warning.
Read more...FDA Advisers Don't Back 'Black Box' Warning for Epilepsy Drugs (HealthDay via Yahoo! News)
THURSDAY, July 10 (HealthDay News) -- Anti-seizure drugs can cause increased suicidal tendencies in patients, but not enough to warrant the government's strongest warning label on them, a U.S. health advisory panel concluded Thursday.
Read more...